Pay in 4 interest-free payments of $6.43 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Clinical trials, including STEP 4 and SURMOUNT-4 (see the semaglutide and tirzepatide sections below) support the idea that discontinuing medications at the patients desired goal weight may lead to weight regain, and therefore is typically not recommended
The cost can be a significant consideration for long-term use
The big issue with Hims is that we had an agreement that the mass compounding would stop and unfortunately it didnt stop, Ludovic Helfgott, executive vice president of product and portfolio strategy at Novo, said in an interview
Key takeaways Zepbound (tirzepatide) is a once-weekly injection approved to treat obesity and overweight, producing an average weight loss of up to 21% in clinical studies
